Amantadine as a drug to mitigate the effects of COVID-19

Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/41235

metadata.artigo.dc.title:	Amantadine as a drug to mitigate the effects of COVID-19
metadata.artigo.dc.creator:	Abreu, Gonzalo Emiliano Aranda Aguilar, María Elena Hernández Covarrubias, Deissy Herrera Durán, Fausto Rojas
metadata.artigo.dc.subject:	COVID-19 Amantadine Viroporin Docking
metadata.artigo.dc.publisher:	Elsevier
metadata.artigo.dc.date.issued:	Jul-2020
metadata.artigo.dc.identifier.citation:	ABREU, G. E. A. et al. Amantadine as a drug to mitigate the effects of COVID-19. Medical Hypotheses, [S.l.], v. 140, July 2020.
metadata.artigo.dc.description.abstract:	The SARS-CoV-2 virus has spread around the world. At this time, there is no vaccine that can help people prevent the spread of coronavirus. We are proposing amantadine as a drug that can be used to mitigate the effects of the virus. It is demonstrated by docking models how amantadine can exert its action on Coronavirus viroporin E.
metadata.artigo.dc.identifier.uri:	https://www.sciencedirect.com/science/article/pii/S030698772030654X http://repositorio.ufla.br/jspui/handle/1/41235
metadata.artigo.dc.language:	en_US
Appears in Collections:	FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Files in This Item:

There are no files associated with this item.